Peyrin‐Biroulet, L., Arkkila, P., Armuzzi, A., Danese, S., Ferrante, M., Jahnsen, J., . . . Atreya, R. (2024). Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials. BMC gastroenterology, 24(1), . doi:10.1186/s12876-024-03163-5
Chicago ZitierstilPeyrin‐Biroulet, Laurent, et al. "Comparative Efficacy and Safety of Subcutaneous Infliximab and Vedolizumab in Patients With Crohn’s Disease and Ulcerative Colitis Included in Randomised Controlled Trials." BMC Gastroenterology 24, no. 1 (2024).
MLA ZitierstilPeyrin‐Biroulet, Laurent, et al. "Comparative Efficacy and Safety of Subcutaneous Infliximab and Vedolizumab in Patients With Crohn’s Disease and Ulcerative Colitis Included in Randomised Controlled Trials." BMC Gastroenterology 24.1 (2024).